Mechanographic analysis of the timed 4 stair climb test - methodology and reference data of healthy children and adolescents.


Journal

Journal of musculoskeletal & neuronal interactions
ISSN: 1108-7161
Titre abrégé: J Musculoskelet Neuronal Interact
Pays: Greece
ID NLM: 101084496

Informations de publication

Date de publication:
01 03 2023
Historique:
entrez: 1 3 2023
pubmed: 2 3 2023
medline: 3 3 2023
Statut: ppublish

Résumé

The timed 4 stair climb test (4SC) is an accepted and widely used tool to assess motor function of patients with neuromuscular diseases. We aimed to establish reference data for the 4SC, and for mechanographic analysis of ascent (4SC-Up) and descent (4SC-Dn) in healthy children and adolescents. We used a custom-made staircase measuring device to assess force, power and velocity during the ascent of 4 stairs in healthy subjects. Secondary outcome measures included mechanographic analyses such as the Chair-Rising-test and the myometric Grip Force-test. Data of 288 participants aged 4 to 16 years (144 males, 144 females) were analyzed. A simple algorithm integrating the minimal applied force was used to compensate for different movement strategies. Percentiles for average power, force and horizontal velocity were calculated. While results of the 4SC-Up test showed no age or gender dependency, we found 4SC-Dn results to be age dependent. Mean device measured times were significantly shorter than manually measured times (mean difference -0.19 s; p<0.001). Mechanographic analysis of the 4SC appears to be a promising tool for evaluation of muscle strength and function of the lower extremities as it enables physically exact measurements of a highly relevant activity of daily living.

Identifiants

pubmed: 36856096
pmc: PMC9976186

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4-25

Déclaration de conflit d'intérêts

David Christof Schorling participated in workshops sponsored by Biogen and Roche, received compensations for consulting services from Pfizer. Rainer Rawer is employed at the company Novotec GmbH, which manufactures and distributes the devices used in this study. Astrid Pechmann received compensation for presentations and training activities from Biogen, received research funding from Biogen and Novartis. Janbernd Kirschner received research funding and/or compensation for presentations and consulting services from Biogen, Novartis, Pfizer, PTC, Roche and Sarepta.The remaining authors have nothing to declare.

Références

J Bone Joint Surg Am. 1980 Jul;62(5):749-57
pubmed: 7391098
J Musculoskelet Neuronal Interact. 2013 Jun;13(2):213-26
pubmed: 23728108
Neuromuscul Disord. 2019 Aug;29(8):585-600
pubmed: 31421973
Pediatr Phys Ther. 2004 Summer;16(2):90-8
pubmed: 17057533
Muscle Nerve. 2013 Jul;48(1):32-54
pubmed: 23677550
J Biomech. 1988;21(9):733-44
pubmed: 3182877
PLoS Med. 2020 Sep 21;17(9):e1003222
pubmed: 32956407
Rev Bras Fisioter. 2010 Nov-Dec;14(6):518-26
pubmed: 21340247
Neurology. 2017 Oct 24;89(17):1811-1820
pubmed: 28972192
J Rehabil Res Dev. 2014;51(3):335-50
pubmed: 25019658
J Musculoskelet Neuronal Interact. 2013 Dec;13(4):480-6
pubmed: 24292618
Neuromuscul Disord. 2007 Oct;17(9-10):693-7
pubmed: 17658255
J Neurosurg Spine. 2019 Jan 18;:1-5
pubmed: 30660112
Neuromuscul Disord. 2018 Jan;28(1):4-15
pubmed: 29203355
J Musculoskelet Neuronal Interact. 2015 Sep;15(3):257-63
pubmed: 26350944
Phys Ther. 1992 Feb;72(2):115-22; discussion 122-6
pubmed: 1549632
Lancet. 2017 Sep 23;390(10101):1489-1498
pubmed: 28728956
Neuromuscul Disord. 2001 Jul;11(5):441-6
pubmed: 11404114
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
J Musculoskelet Neuronal Interact. 2011 Mar;11(1):27-33
pubmed: 21364272
Muscle Nerve. 2014 Oct;50(4):477-87
pubmed: 25042182
J Musculoskelet Neuronal Interact. 2013 Sep;13(3):297-311
pubmed: 23989251
Pediatr Res. 2006 Jan;59(1):46-9
pubmed: 16327004
J Am Med Dir Assoc. 2021 Apr;22(4):882-883
pubmed: 33596410
Gait Posture. 2002 Feb;15(1):32-44
pubmed: 11809579
Phys Ther. 2017 Jul 01;97(7):767-773
pubmed: 28444350
Disabil Rehabil. 2014;36(22):1918-23
pubmed: 24499260

Auteurs

David C Schorling (DC)

Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Rainer Rawer (R)

Novotec GmbH, Pforzheim, Germany.

Imke Kuhlmann (I)

Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Cornelia Müller (C)

Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Astrid Pechmann (A)

Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Janbernd Kirschner (J)

Department of Neuropediatrics and Muscle Disorders, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH